CRT 2024

CARDIOTUBE INTERVIEW - Renal Denervation Post Approval Who Should Get Treated

Interviewer(s)

• 

  Michael H. Joner, MD

  Associate Professor Interventional Cardiology
  Deutsches Herzzentrum Muenchen
  Munich, Bayern, Germany

  Disclosure(s): Abbott Medical GmbH: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Alchimedics S.A.S.: Consultant (Ongoing); AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Biotronik: Consultant (Ongoing); Boston Scientific: Consultant (Ongoing); Cardiac Dimensions: Consultant (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Infraredx: Grant/Research Support (Ongoing); Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 16, 2023); Shockwave: Consultant (Ongoing); TriCares: Consultant (Ongoing); Veryan: Consultant (Ongoing)

Interviewee(s)

• 

  Felix Mahfoud, MD

  Professor
  Saarland University Hospital
  Homburg/Saar, Saarland, Germany

  No relationships to disclose